3 February 2016 - Martin Shkreli anticipated huge profits from raising the price of a decades-old drug for an infectious disease, belying any notion that helping patients was foremost in his mind, according to information released by congressional investigators on Tuesday.

For more details, go to: http://www.nytimes.com/2016/02/03/business/drug-makers-calculated-price-increases-with-profit-in-mind-memos-show.html?emc=edit_th_20160203&nl=todaysheadlines&nlid=20088616&_r=0